Big Pharma
-
News
Artificial Intelligence has created a new drug
Now the pharmaceutical industry unloads everything on AI: it is they who create the most suitable drugs for Man | First tests on…
Leggi » -
News
AstraZeneca is considering spin-off of its China operations
This is why AstraZeneca is considering a spin off of its activities in China The growing geopolitical tensions between China…
Leggi » -
News
The Best Workplaces in Pharma & Biotechnology 2023 Ranking
BEST WORKPLACES™ IN PHARMA & BIOTECHNOLOGY 2023 RANKING Here are the 10 best companies to work for this year in Italy in…
Leggi » -
First floor
Massive adhesion of Angelini Pharma's ISF to the two-hour strike
The company RSU issued this statement after the two-hour strike that took place yesterday from 3…
Leggi » -
News
AI in pharmaceutical research: promising applications, risks
The use of AI in drug design is growing rapidly and is set to become an increasingly important tool in…
Leggi » -
News
The excellence of the Italian pharmaceutical sector in the Nomisma Observatory dedicated to "Fab13"
The excellence of the Italian pharmaceutical sector in the Nomisma Observatory dedicated to "Fab13" Nomisma – 26 April 2023 The 13 champion companies of…
Leggi » -
News
ALFASIGMA: a difficult comparison
We report in full the unitary union statement drawn up after the last meeting between the workers' representatives and the ALFASIGMA company assisted by…
Leggi » -
First floor
Janssen Italy. To intercept opportunities, informers are cut.
The unions take to the streets and call a strike against the layoffs at Janssen of Cologno Monzese, a pharmaceutical company in…
Leggi » -
News
The EU Commission's legislative proposals seriously damage the competitiveness of the European pharmaceutical industry
The EU's long-term competitiveness strategy must be applied to EU pharmaceutical legislation EFPIA – 21.03.2023 EFPIA invites…
Leggi » -
News
Novartis will proceed with the repurchase of treasury shares (buyback)
A maxi-share buyback program starts for Novartis Share buybacks continue at Novartis: starting tomorrow a…
Leggi »